← Back to Search

Dietary Supplement

Beet Juice Supplementation for Coronary Artery Disease

N/A
Recruiting
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to following 2 weeks of experimental condition
Awards & highlights

Study Summary

This trial looks at whether beet juice can help improve vascular and inspiratory muscle function in older adults with coronary artery disease.

Who is the study for?
This trial is for adults aged 60-85 with stable coronary artery disease (CAD), confirmed by an angiogram or history of heart issues, who are on optimal medical therapy. Participants must be non-smokers, not engaged in regular aerobic exercise, and women should be postmenopausal. Those with recent heart attacks, strokes, severe lung disease, uncontrolled high blood pressure or certain infections like hepatitis B/C and HIV cannot join.Check my eligibility
What is being tested?
The study investigates the effects of beet juice supplementation on blood vessel and breathing muscle function in older adults with CAD. It compares two types of beetroot juice: one rich in nitrates and one depleted of nitrates to see which might improve these functions better.See study design
What are the potential side effects?
While the trial does not specify side effects related to beet juice consumption directly, potential general side effects may include changes in bowel movements due to increased fiber intake from the juice and possible stomach discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to following 2 weeks of experimental condition
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to following 2 weeks of experimental condition for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in endothelial function
Change in inspiratory muscle function
Secondary outcome measures
Change in central arterial hemodynamics
Arterial Stiffness
Change in functional capacity
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Nitrate rich beetroot juiceActive Control1 Intervention
Group II: Nitrate depleted beetroot juicePlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,633 Total Patients Enrolled
44 Trials studying Coronary Artery Disease
30,126 Patients Enrolled for Coronary Artery Disease

Media Library

Nitrate depleted beetroot juice (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04920799 — N/A
Coronary Artery Disease Research Study Groups: Nitrate rich beetroot juice, Nitrate depleted beetroot juice
Coronary Artery Disease Clinical Trial 2023: Nitrate depleted beetroot juice Highlights & Side Effects. Trial Name: NCT04920799 — N/A
Nitrate depleted beetroot juice (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04920799 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applications for the trial being accepted currently?

"Affirmative, information on clinicaltrials.gov confirms that this experiment is currently taking in applicants. It was first announced on November 12th 2021 and most recently revised on January 14th 2022; the study requires 24 participants to be enrolled at a single facility."

Answered by AI

Would I qualify for participation in this trial?

"This medical experiment is enrolling 24 participants aged between 60 and 85, who have been diagnosed with coronary artery disease. Furthermore, potential patients must be either male or post-menopausal female (whether naturally or surgically), and able to provide consent for the trial."

Answered by AI

What are the main goals of this research project?

"Primarily, this clinical trial seeks to assess changes in endothelial function over an initial two-week period. Secondary metrics include alterations in central arterial hemodynamics measured with the SphygmoCor XCEL device, functional capacity evaluated via the Duke Activity Status Index, and microvascular functions examined through ultrasound imaging of brachial artery blood flow and diameter during submaximal handgrip exercise."

Answered by AI

Does this trial seek participants aged twenty and over?

"This research is seeking participants who are between 60 and 85 years old."

Answered by AI

What is the capacity of this clinical experiment?

"That is correct. Clinicaltrials.gov indicates that this particular trial, which was initially posted on November 12th 2021, is open for enrollment of 24 participants within 1 medical centre."

Answered by AI
~9 spots leftby Aug 2025